GHRP-2 (10mg Vial) Dosage Protocol

GHRP-2 (10 mg Vial) Dosage Protocol

Quickstart Highlights

GHRP-2 dosage protocols leverage this potent synthetic hexapeptide (pralmorelin) that stimulates growth hormone (GH) release by acting as a ghrelin receptor agonist in the pituitary and hypothalamus[1][2]. Researchers and clinicians have explored GHRP-2 as a diagnostic GH stimulant and investigated its potential for supporting healthy GH secretion patterns, lean body composition, recovery, and sleep quality[3][4]. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

  • Reconstitute: Add 3.0 mL bacteriostatic water → ~3.33 mg/mL concentration.
  • Typical daily range: 100–300 mcg once daily (gradual titration).
  • Easy measuring: At 3.33 mg/mL, 1 unit = 0.01 mL ≈ 33.3 mcg on a U‑100 insulin syringe.
  • Timing: Bedtime administration aligns with natural nocturnal GH secretion[5]; empty stomach preferred.
  • Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 28 days[6][7].
    • GHRP-2 Vial

    Dosing & Reconstitution Guide

    Educational guide for reconstitution and daily dosing

    Standard / Gradual Approach (3 mL = ~3.33 mg/mL)

    Week Daily Dose (mcg) Units (per injection) (mL)
    Weeks 1–2 100 mcg 3 units (0.03 mL)
    Weeks 3–4 150 mcg 4.5 units (0.045 mL)
    Weeks 5–8 200 mcg 6 units (0.06 mL)
    Weeks 9–12 250–300 mcg 7.5–9 units (0.075–0.09 mL)

    Frequency: Inject once daily subcutaneously at bedtime on an empty stomach (at least 2–3 hours after the last meal) to maximize the GH pulse[5]. For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

    Reconstitution Steps

  • Draw 3.0 mL bacteriostatic water with a sterile syringe.
  • Inject slowly down the vial wall; avoid foaming.
  • Gently swirl/roll until dissolved (do not shake).
  • Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within 28 days[8].

    • Advanced / Multiple Daily Dosing (Experienced Research Use Only)

    In research settings exploring enhanced GH release, protocols have used 2–3 injections per day[4]. Be aware that chronic high-frequency stimulation can lead to receptor desensitization (tachyphylaxis)[9][10].

    Phase Dose per Injection (mcg) Frequency Units (per injection) (mL)
    Phase 1 (Weeks 1–2) 100 mcg Twice daily 3 units (0.03 mL)
    Phase 2 (Weeks 3–4) 150 mcg Twice daily 4.5 units (0.045 mL)
    Phase 3 (Weeks 5–8) 200 mcg 2–3× daily 6 units (0.06 mL)

    A “5 days on / 2 days off” cycle is often suggested to help restore receptor sensitivity[9]. Even with breaks, be mindful that chronic stimulation can attenuate the GH response over time.

    Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

    Supplies Needed

    Plan based on an 8–12 week daily protocol with gradual titration (once‑daily regimen).

  • Peptide Vials (GHRP-2, 10 mg each):

    • 8 weeks ≈ 1 vial (~9.1 mg total usage)
    • 12 weeks ≈ 2 vials (~15–16 mg total)
    • 16 weeks ≈ 3 vials (~22–23 mg total)
  • Insulin Syringes (U‑100, 0.3 mL or 0.5 mL recommended):

    • Per week: 7 syringes (1/day)
    • 8 weeks: 56 syringes
    • 12 weeks: 84 syringes
    • 16 weeks: 112 syringes
  • Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

    • 8 weeks (1 vial): 3 mL → 1 × 10 mL bottle
    • 12 weeks (2 vials): 6 mL → 1 × 10 mL bottle
    • 16 weeks (3 vials): 9 mL → 1 × 10 mL bottle
  • Alcohol Swabs: One for the vial stopper + one for the injection site each day.

    • Per week: 14 swabs (2/day)
    • 8 weeks: 112 swabs → recommend 2 × 100‑count boxes
    • 12 weeks: 168 swabs → recommend 2 × 100‑count boxes
    • 16 weeks: 224 swabs → recommend 3 × 100‑count boxes
    • GHRP-2 Vial

    View Supplier

    Insulin Syringes

    View Supplier

    Bacteriostatic Water

    View Supplier

    Alcohol Pads

    View Supplier

    Protocol Overview

    Concise summary of the once‑daily regimen.

  • Goal: Support pulsatile GH release for research into body composition, recovery, and sleep quality[4].
  • Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired).
  • Dose Range: 100–300 mcg daily with gradual titration.
  • Reconstitution: 3.0 mL per 10 mg vial (~3.33 mg/mL) for accurate unit measurements.
  • Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.